Personalis
Julie Meyer has significant work experience in the field of strategic business development and pharmaceutical partnering, with a particular focus on oncology diagnostics and next-generation sequencing products. Julie currently works as the Director of Strategic Business Development at Personalis, Inc., where they identify and develops programs within the pharmaceutical industry that would benefit from design-controlled, regulatory-approved, NGS diagnostics. Prior to this, Julie served as the Director of Pharma CDx Business Development at ArcherDX, Inc. from 2020 to 2021. From 2016 to 2020, they held the position of Manager of Pharma Partnering at Personal Genome Diagnostics, where they closed genomic profiling deals and secured strategic partnerships for a portfolio of kit-based in vitro diagnostic products. Before that, Julie worked as a Senior Strategic Account Manager at QIAGEN from 2004 to 2015, managing multi-million dollar territories and delivering revenue growth. Julie began their career as a Research Technologist at the Roswell Park Cancer Institute from 2002 to 2004.
Julie Meyer attended the University of Rochester from 1998 to 2002, where they earned dual Bachelor's degrees in Biology and Psychology. Julie is currently enrolled in the HMX Fundamentals/Pro online certificate program at Harvard Medical School, focusing on Immunology and Immuno-oncology.
This person is not in any offices
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.